{"denoms":[{"counts":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"3"}],"units":"Participants"}],"groups":[{"description":"Phase I/II study on the backbone of high-dose melphalan on day -2 pre-autologous hematopoietic cell transplantation (AHCT)\n\n•Addition of an increasing number of doses of Carfilzomib (CFZ) in the early post-AHCT period introduced in a step-wise fashion in 3 successive cohorts of 3 to 15 subjects:\n\nCohort 1: add CFZ 20 mg/m\\^2 intravenous (IV) on days +1, +2\n\nCohort 2 : add CFZ 20 mg/m\\^2 IV on days: +1, +2, +8, +9\n\nCohort 3: add CFZ 20 mg/m\\^2 IV on days: +1, +2, +8, +9 and add an early post-AHCT consolidation following engraftment: CFZ 20 mg/m\\^2 IV given on days 42-43 then CFZ 56 mg/m\\^2 IV given on days 49-50, 56-57, then on days 70.","id":"BG000","title":"Cohort 1- CFZ 20 mg/m^2 (Day 1,2)"},{"description":"Phase I/II study on the backbone of high-dose melphalan on day -2 pre-autologous hematopoietic cell transplantation (AHCT)\n\n•Addition of an increasing number of doses of Carfilzomib (CFZ) in the early post-AHCT period introduced in a step-wise fashion in 3 successive cohorts of 3 to 15 subjects:\n\nCohort 1: add CFZ 20 mg/m\\^2 intravenous (IV) on days +1, +2\n\nCohort 2 : add CFZ 20 mg/m\\^2 IV on days: +1, +2, +8, +9\n\nCohort 3: add CFZ 20 mg/m\\^2 IV on days: +1, +2, +8, +9 and add an early post-AHCT consolidation following engraftment: CFZ 20 mg/m\\^2 IV given on days 42-43 then CFZ 56 mg/m\\^2 IV given on days 49-50, 56-57, then on days 70.","id":"BG001","title":"Cohort 2- CFZ 20 mg/m^2 (Day 1,2,8,9)"},{"description":"Phase I/II study on the backbone of high-dose melphalan on day -2 pre-autologous hematopoietic cell transplantation (AHCT)\n\n•Addition of an increasing number of doses of Carfilzomib (CFZ) in the early post-AHCT period introduced in a step-wise fashion in 3 successive cohorts of 3 to 15 subjects:\n\nCohort 1: add CFZ 20 mg/m\\^2 intravenous (IV) on days +1, +2\n\nCohort 2 : add CFZ 20 mg/m\\^2 IV on days: +1, +2, +8, +9\n\nCohort 3: add CFZ 20 mg/m\\^2 IV on days: +1, +2, +8, +9 and add an early post-AHCT consolidation following engraftment: CFZ 20 mg/m\\^2 IV given on days 42-43 then CFZ 56 mg/m\\^2 IV given on days 49-50, 56-57, then on days 70.","id":"BG002","title":"Cohort 3-CFZ 20 mg/m^2 (Day1,2,8,9/AHCT)"},{"description":"Total of all reporting groups","id":"BG003","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG003","value":"0"}]}],"title":"<=18 years"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG003","value":"3"}]}],"title":"Between 18 and 65 years"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG003","value":"0"}]}],"title":">=65 years"}],"paramType":"NUMBER","title":"Age, Categorical","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"10.39","value":"49.6"},{"groupId":"BG003","spread":"10.39","value":"49.6"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG003","value":"1"}]}],"title":"Female"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG003","value":"2"}]}],"title":"Male"}],"paramType":"NUMBER","title":"Gender","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG003","value":"0"}]}],"title":"Hispanic or Latino"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG003","value":"3"}]}],"title":"Not Hispanic or Latino"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG003","value":"0"}]}],"title":"Unknown or Not Reported"}],"paramType":"NUMBER","title":"Ethnicity (NIH/OMB)","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG003","value":"0"}]}],"title":"American Indian or Alaska Native"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG003","value":"0"}]}],"title":"Asian"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG003","value":"0"}]}],"title":"Native Hawaiian or Other Pacific Islander"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG003","value":"1"}]}],"title":"Black or African American"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG003","value":"2"}]}],"title":"White"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG003","value":"0"}]}],"title":"More than one race"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG003","value":"0"}]}],"title":"Unknown or Not Reported"}],"paramType":"NUMBER","title":"Race (NIH/OMB)","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG003","value":"3"}]}],"title":"United States"}],"paramType":"NUMBER","title":"Region of Enrollment","unitOfMeasure":"participants"}]}